tiprankstipranks
Bicycle Therapeutics Ltd (BCYC)
NASDAQ:BCYC
US Market
BCYC
Bicycle Therapeutics
RESEARCH TOOLSreports
Want to see BCYC full AI Analyst Report?

Bicycle Therapeutics (BCYC) Income Statement

412 Followers

Bicycle Therapeutics Income Statement

Last quarter (Q4 2025), Bicycle Therapeutics's total revenue was $47.95M, an increase of 1193.28% from the same quarter last year. In Q4, Bicycle Therapeutics's net income was $-20.15M. See Bicycle Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 72.59M$ 35.27M$ 26.98M$ 14.46M$ 11.70M
Gross Profit
$ 72.59M$ -137.69M$ -129.52M$ 14.46M$ 11.70M
Operating Expenses
$ 349.62M$ 72.18M$ 60.43M$ 131.12M$ 77.31M
Depreciation and Amortization
$ 6.44M$ 7.18M$ 6.55M$ 3.69M$ 1.41M
EBITDA
$ -276.86M$ -164.89M$ -183.40M$ -107.21M$ -64.09M
Operating Income
$ -247.06M$ -209.87M$ -189.95M$ -116.65M$ -65.62M
Other Income/Expenses
$ 28.98M$ 36.08M$ 10.74M$ 2.41M$ -2.86M
Pretax Income
$ -254.32M$ -173.80M$ -179.21M$ -114.24M$ -68.48M
Net Income
$ -218.96M$ -169.03M$ -180.66M$ -112.72M$ -66.82M
Per Share Metrics
Basic EPS
$ -3.16$ -2.91$ -5.08$ -3.80$ -2.67
Diluted EPS
$ -3.16$ -2.90$ -5.08$ -3.80$ -2.67
Weighted Average Shares Outstanding
 69.28M 58.21M 35.59M 29.66M 25.06M
Weighted Average Shares Outstanding (Diluted)
 69.28M 58.21M 35.59M 29.66M 25.06M
Currency in USD

Bicycle Therapeutics Earnings and Revenue History